Investment
Features
FeesSafety
Academy
More
Pluang+

Aktis Oncology undervalued despite strong cash and promising drug programs, with key data expected in 2027

Market News
14 Oct 2026
Seeking Alpha
View Source
Bullish
Aktis Oncology undervalued despite strong cash and promising drug programs, with key data expected in 2027

Aktis Oncology is trading below its IPO price despite holding $517.3 million in cash and a $1.2 billion partnership with Eli Lilly, giving it financial stability through 2029. The company is developing two innovative radiopharmaceutical drugs, AKY-1189 and AKY-2519, both with Fast Track status and early positive data reducing development risks. The growing use of Padcev expands the market opportunity for Aktis' treatments, positioning the company for significant growth ahead of key Phase 1b study results expected in the first quarter of 2027.

Aktis Oncology is the subject of this update, with Pluang providing a snapshot of the health sector market. Of 150 priced health-sector US stocks on Pluang, 90 rose and 60 fell today. Notable movers include Liquidia Corporation (LQDA) at USD 33.90 with a 1-day change of +26.45%, MiniMed Group Inc. (MMED) at USD 16.71 with a 1-day change of -9.18%, and Alumis Inc. (ALMS) at USD 6.08 with a 1-day change of -7.39%, as of Oct 15, 2026 03:02 WIB.

More News

Lakefront sells early-stage CAR-T cell therapy programs to Armed Cell Therapeutics for up to $230M plus royalties

Lakefront sells early-stage CAR-T cell therapy programs to Armed Cell Therapeutics for up to $230M plus royalties

Lakefront Biotherapeutics has completed the sale of its preclinical CAR-T cell therapy programs to Belgium-based Armed Cell Therapeutics. The deal includes an upfront payment of €8 million, potential milestone payments up to $230 million, and a low s...

Company Fundamentals
Bullish
42 minutes ago
PNC expects strong Q3 earnings growth despite fee income drop, with mixed operational outlook.

PNC expects strong Q3 earnings growth despite fee income drop, with mixed operational outlook.

PNC Financial Services Group is set to report its Q3 2026 earnings with analysts forecasting earnings of around $4.91 per share and revenue near $6.61 billion, reflecting solid growth. The bank anticipates a 3%–3.5% rise in net interest income and 1%...

Company Fundamentals
Neutral
43 minutes ago
Leonardo DRS wins 10-year NASA SEWP VI contract to supply federal agencies with defense tech through 2036

Leonardo DRS wins 10-year NASA SEWP VI contract to supply federal agencies with defense tech through 2036

Leonardo DRS secured a 10-year prime contract under NASA's SEWP VI program, enabling federal agencies to quickly procure its defense products and services until 2036. This contract extends DRS's role as a SEWP prime contractor, supporting key militar...

Market News
Bullish
43 minutes ago
Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.

Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.

Honey Badger Silver announced promising assay results from its first exploration program at the Yava Project in Nunavut, revealing high-grade silver, copper, gold, zinc, and lead samples. This marks the first systematic work at Yava in nearly two dec...

Market News
Bullish
1 hour ago
Top tech leaders from major Minnesota firms to gather at Minneapolis Summit on Oct 27 for AI, cybersecurity, and innovation talks

Top tech leaders from major Minnesota firms to gather at Minneapolis Summit on Oct 27 for AI, cybersecurity, and innovation talks

The 12th Annual Minneapolis C-Level Technology Leadership Summit will take place on October 27 at Interlachen Country Club, Edina, bringing together senior technology executives from leading Minnesota organizations like Cargill, Land O’Lakes, and Blu...

Others
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App